Capstone Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $2,513 - $2,908	-29 Reduced 0.27%	10,900 $944,000
Q1 2023 May 09, 2023	BUY	$87.74 - $117.27 $2,544 - $3,400	29 Added 0.27%	10,929 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $586,993 - $713,212	8,212 Added 305.51%	10,900 $903,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $691,695 - $863,129	-9,312 Reduced 77.6%	2,688 $207,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $316,481 - $384,072	-4,235 Reduced 26.09%	12,000 $906,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $132,948 - $165,156	1,831 Added 12.71%	16,235 $1.42 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $628,287 - $1.15 Million	-8,742 Reduced 37.77%	14,404 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $386,135 - $602,963	-4,854 Reduced 17.34%	23,146 $2.86 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $35,685 - $48,425	-500 Reduced 1.75%	28,000 $2.37 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $385,620 - $518,220	6,000 Added 26.67%	28,500 $2.41 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $640,300 - $808,545	-9,500 Reduced 29.69%	22,500 $1.52 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $160,700 - $187,800	-2,000 Reduced 5.88%	32,000 $2.74 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $84,200 - $98,620	-1,000 Reduced 2.86%	34,000 $3.02 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $2.8 Million - $3.71 Million	35,000 New	35,000 $2.98 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $494,065 - $643,695	-6,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $504,855 - $602,095	6,500 New	6,500 $527,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $1.15 Million - $1.35 Million	-14,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.14 Million - $1.35 Million	14,200	14,200 $1.32 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account